MOXIFLOXACIN

MOXIFLOXACIN was reported 20741 times

MOXIFLOXACIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NPM1 GENE MUTATION 11 0.7857
1 IRIS TRANSILLUMINATION DEFECT 99 0.5294
2 SPIROMETRY ABNORMAL 178 0.2977
3 MITE ALLERGY 169 0.2580
4 TOTAL LUNG CAPACITY INCREASED 69 0.2537
5 PULMONARY VASCULITIS 122 0.2268
6 MYCOTIC ALLERGY 171 0.2000
7 TYPE 2 LEPRA REACTION 37 0.1979
8 TOTAL LUNG CAPACITY ABNORMAL 75 0.1928
9 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 20 0.1905
10 DUST ALLERGY 175 0.1784
11 CAPILLARITIS 45 0.1630
12 IRIS HYPOPIGMENTATION 17 0.1589
13 KERATITIS FUNGAL 33 0.1587
14 CHOROIDITIS 58 0.1551
15 INFECTIVE KERATITIS 11 0.1549
16 PERSISTENT CORNEAL EPITHELIAL DEFECT 17 0.1441
17 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 72 0.1377
18 MYCOBACTERIAL PERITONITIS 13 0.1368
19 PIGMENT DISPERSION SYNDROME 12 0.1263
20 CHIMERISM 11 0.1236
21 C-REACTIVE PROTEIN 111 0.1197
22 CONJUNCTIVITIS ALLERGIC 173 0.1167
23 GRIP STRENGTH 24 0.1048
24 MYCOBACTERIUM FORTUITUM INFECTION 19 0.1027
25 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 74 0.1010
26 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 22 0.0995
27 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 17 0.0934
28 RHODOCOCCUS INFECTION 15 0.0904
29 KERATITIS BACTERIAL 14 0.0859
30 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 23 0.0849
31 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 27 0.0806
32 NEURITIS 123 0.0796
33 MYCOBACTERIUM ABSCESSUS INFECTION 55 0.0769
34 CORNEAL INFILTRATES 24 0.0764
35 NECROTISING SCLERITIS 11 0.0759
36 SWOLLEN JOINT COUNT 18 0.0720
37 NASAL OEDEMA 129 0.0713
38 DEEP VEIN THROMBOSIS POSTOPERATIVE 140 0.0699
39 CORNEAL DECOMPENSATION 11 0.0683
40 CONTRAST MEDIA ALLERGY 118 0.0644
41 BRONCHIOLITIS OBLITERANS SYNDROME 11 0.0629
42 NORMOCHROMIC NORMOCYTIC ANAEMIA 179 0.0595
43 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 39 0.0584
44 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 112 0.0549
45 TOXIC ANTERIOR SEGMENT SYNDROME 59 0.0541
46 PERIORBITAL PAIN 44 0.0519
47 HYPOPYON 42 0.0507
48 CORNEAL PERFORATION 32 0.0507
49 OBLITERATIVE BRONCHIOLITIS 65 0.0495
50 CORYNEBACTERIUM INFECTION 26 0.0486
51 CORNEAL EPITHELIUM DEFECT 28 0.0482
52 SPUTUM PURULENT 31 0.0471
53 EYE INFECTION FUNGAL 18 0.0465
54 RESPIRATORY SYMPTOM 132 0.0464
55 FACET JOINT SYNDROME 150 0.0460
56 SWOLLEN JOINT COUNT INCREASED 146 0.0457
57 X-RAY ABNORMAL 80 0.0447
58 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 25 0.0446
59 TOXIC OPTIC NEUROPATHY 19 0.0438
60 LEISHMANIASIS 12 0.0414
61 LUPUS VULGARIS 52 0.0413
62 DYSBIOSIS 33 0.0402
63 TENDON DISCOMFORT 30 0.0397
64 OTOTOXICITY 73 0.0394
65 PERIPHERAL VENOUS DISEASE 161 0.0394
66 MYCOBACTERIUM CHELONAE INFECTION 29 0.0392
67 FORCED EXPIRATORY VOLUME DECREASED 109 0.0384
68 CORNEAL DEPOSITS 28 0.0376
69 HERPES ZOSTER MENINGOENCEPHALITIS 13 0.0361
70 EYE ABSCESS 11 0.0361
71 RHEUMATIC FEVER 151 0.0338
72 OESOPHAGEAL SPASM 62 0.0336
73 MYCOBACTERIAL INFECTION 57 0.0331
74 ACINETOBACTER INFECTION 36 0.0329
75 PERIOSTITIS 14 0.0324
76 TRICHOGLOSSIA 13 0.0317
77 MYCOBACTERIUM AVIUM COMPLEX INFECTION 85 0.0316
78 PNEUMONIA HAEMOPHILUS 15 0.0309
79 CORNEAL OEDEMA 69 0.0308
80 PARADOXICAL DRUG REACTION 112 0.0304
81 MENINGITIS TUBERCULOUS 16 0.0286
82 RETINITIS 49 0.0283
83 EYELID PAIN 57 0.0280
84 ANTERIOR CHAMBER CELL 20 0.0280
85 PORPHYRIA ACUTE 39 0.0272
86 THERAPEUTIC PRODUCT CROSS-REACTIVITY 24 0.0269
87 PSOAS ABSCESS 16 0.0257
88 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 164 0.0252
89 CORNEAL TRANSPLANT 18 0.0230
90 PULMONARY ALVEOLAR HAEMORRHAGE 129 0.0230
91 ENDOPHTHALMITIS 137 0.0228
92 C-REACTIVE PROTEIN ABNORMAL 146 0.0227
93 SECONDARY IMMUNODEFICIENCY 27 0.0222
94 NEUROLOGICAL SYMPTOM 126 0.0220
95 RHEUMATOID FACTOR POSITIVE 127 0.0220
96 ATYPICAL MYCOBACTERIAL INFECTION 31 0.0219
97 CORNEAL SCAR 11 0.0219
98 RETINAL ISCHAEMIA 13 0.0213
99 ULCERATIVE KERATITIS 58 0.0212
100 MUSCLE INJURY 173 0.0209
101 ARTERIOSCLEROSIS CORONARY ARTERY 138 0.0208
102 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 42 0.0203
103 STENOTROPHOMONAS INFECTION 27 0.0199
104 OPTIC NEUROPATHY 42 0.0198
105 CEREBRAL ASPERGILLOSIS 12 0.0195
106 ARTERIOSCLEROSIS 181 0.0192
107 DUODENAL ULCER PERFORATION 138 0.0185
108 DYSMETRIA 11 0.0182
109 ALLERGIC COUGH 14 0.0182
110 JAUNDICE CHOLESTATIC 64 0.0181
111 OBSTRUCTIVE AIRWAYS DISORDER 201 0.0181
112 MULTIPLE-DRUG RESISTANCE 56 0.0180
113 BRONCHITIS CHRONIC 44 0.0180
114 TEMPERATURE REGULATION DISORDER 40 0.0179
115 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 128 0.0178
116 FULL BLOOD COUNT ABNORMAL 188 0.0178
117 SMALL FIBRE NEUROPATHY 13 0.0176
118 LOSS OF EMPLOYMENT 53 0.0175
119 BACILLUS INFECTION 11 0.0174
120 LIP DRY 157 0.0173
121 NASAL CRUSTING 11 0.0169
122 DRUG RESISTANCE 433 0.0168
123 NOCARDIOSIS 42 0.0164
124 BONE EROSION 58 0.0164
125 RHINITIS ALLERGIC 73 0.0164
126 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 81 0.0162
127 DISSEMINATED TUBERCULOSIS 41 0.0160
128 SARCOIDOSIS 75 0.0158
129 SUPERFICIAL INJURY OF EYE 17 0.0156
130 FOLLICULITIS 163 0.0155
131 HELICOBACTER INFECTION 157 0.0153
132 PRODUCT MONITORING ERROR 22 0.0152
133 HYPOMANIA 56 0.0152
134 BURSITIS 182 0.0150
135 OESOPHAGEAL PAIN 59 0.0149
136 DISLOCATION OF VERTEBRA 34 0.0149
137 PRODUCT CLOSURE REMOVAL DIFFICULT 15 0.0147
138 NODULE 192 0.0147
139 WHEEZING 871 0.0147
140 CORNEAL OPACITY 20 0.0146
141 NASAL POLYPS 71 0.0144
142 BRONCHIECTASIS 96 0.0142
143 VITREOUS OPACITIES 12 0.0142
144 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 15 0.0141
145 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 231 0.0136
146 MATERNAL EXPOSURE TIMING UNSPECIFIED 51 0.0136
147 VANISHING BILE DUCT SYNDROME 15 0.0135
148 AUTOIMMUNE DISORDER 131 0.0134
149 LYMPHOEDEMA 91 0.0131
150 VASCULITIS 148 0.0127
151 HAND DEFORMITY 163 0.0124
152 ELECTROCARDIOGRAM QT PROLONGED 447 0.0124
153 OEDEMA 656 0.0121
154 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 11 0.0119
155 CORNEAL DISORDER 26 0.0118
156 RETINAL VASCULITIS 14 0.0118
157 PEMPHIGUS 145 0.0116
158 PATHOGEN RESISTANCE 105 0.0115
159 EYE PAIN 644 0.0114
160 IRIDOCYCLITIS 36 0.0114
161 TORSADE DE POINTES 89 0.0113
162 BRAIN ABSCESS 28 0.0111
163 PULMONARY TUBERCULOSIS 47 0.0110
164 SCIATICA 175 0.0110
165 DEAFNESS NEUROSENSORY 36 0.0109
166 CORNEAL ABRASION 15 0.0109
167 VITRITIS 20 0.0108
168 VESTIBULAR DISORDER 13 0.0106
169 PULMONARY FIBROSIS 201 0.0105
170 SPUTUM INCREASED 22 0.0102
171 HEPATOTOXICITY 223 0.0100
172 STEROID DIABETES 15 0.0100
173 FOREIGN BODY SENSATION IN EYES 63 0.0099
174 SYNOVITIS 177 0.0098
175 JOINT RANGE OF MOTION DECREASED 130 0.0097
176 OBESITY 154 0.0097
177 OBSTRUCTIVE SLEEP APNOEA SYNDROME 14 0.0096
178 FIBROMYALGIA 233 0.0096
179 PERICARDITIS 161 0.0096
180 RESPIRATORY TRACT INFECTION 247 0.0095
181 HISTOPLASMOSIS DISSEMINATED 15 0.0094
182 SINUS PAIN 22 0.0094
183 SCLERITIS 15 0.0094
184 ACUTE MYELOID LEUKAEMIA RECURRENT 20 0.0093
185 ENTEROCOCCAL INFECTION 45 0.0093
186 CONJUNCTIVAL HYPERAEMIA 33 0.0092
187 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 231 0.0090
188 CARDIAC MURMUR 77 0.0089
189 IDIOPATHIC INTRACRANIAL HYPERTENSION 20 0.0089
190 HEPATORENAL SYNDROME 15 0.0089
191 HELICOBACTER GASTRITIS 11 0.0089
192 ASPERGILLUS INFECTION 58 0.0088
193 ASTHMA 986 0.0087
194 LOWER LIMB FRACTURE 167 0.0087
195 INTRAOCULAR PRESSURE INCREASED 111 0.0087
196 PHOTOPHOBIA 160 0.0085
197 TENDON PAIN 64 0.0084
198 LUNG NEOPLASM 36 0.0084
199 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 63 0.0084
200 CONTRAINDICATED PRODUCT ADMINISTERED 246 0.0081
201 PRESCRIBED OVERDOSE 157 0.0081
202 RALES 47 0.0081
203 FOOD ALLERGY 61 0.0079
204 GLOSSODYNIA 174 0.0078
205 TYPE IV HYPERSENSITIVITY REACTION 21 0.0077
206 KERATITIS 23 0.0076
207 LIVER INJURY 184 0.0075
208 RADIATION PNEUMONITIS 16 0.0075
209 LYMPHADENITIS 18 0.0074
210 TENDONITIS 115 0.0074
211 OCULAR DISCOMFORT 83 0.0074
212 LUNG DISORDER 362 0.0074
213 PNEUMONIA FUNGAL 29 0.0073
214 FOETAL DEATH 38 0.0073
215 HEPATITIS TOXIC 19 0.0073
216 VENTRICULAR HYPOKINESIA 23 0.0072
217 HAEMOPTYSIS 198 0.0071
218 LONG QT SYNDROME 17 0.0071
219 PULMONARY FUNCTION TEST ABNORMAL 11 0.0071
220 EYE INFLAMMATION 67 0.0070
221 KERATOPATHY 11 0.0069
222 NEPHROGENIC ANAEMIA 32 0.0069
223 HYPOXIA 242 0.0069
224 BLOOD IMMUNOGLOBULIN G DECREASED 17 0.0069
225 FEAR OF DISEASE 12 0.0067
226 TENDON DISORDER 44 0.0067
227 SPUTUM DISCOLOURED 64 0.0067
228 OCULAR HYPERTENSION 13 0.0067
229 IRRITABLE BOWEL SYNDROME 143 0.0067
230 PRODUCTIVE COUGH 317 0.0066
231 OPTIC NEURITIS 60 0.0066
232 DRUG INTOLERANCE 632 0.0065
233 HYPERTRANSAMINASAEMIA 45 0.0065
234 WOUND 180 0.0064
235 PUSTULAR PSORIASIS 22 0.0064
236 FIXED ERUPTION 11 0.0064
237 HYPERLACTACIDAEMIA 17 0.0063
238 NEUROPATHY PERIPHERAL 603 0.0063
239 MUCORMYCOSIS 16 0.0062
240 CYTOMEGALOVIRUS CHORIORETINITIS 12 0.0061
241 CONCOMITANT DISEASE PROGRESSION 12 0.0061
242 EXOSTOSIS 56 0.0061
243 HYPERCHOLESTEROLAEMIA 59 0.0061
244 BLOOD PRESSURE SYSTOLIC ABNORMAL 15 0.0061
245 DRUG-INDUCED LIVER INJURY 190 0.0060
246 HYPERPARATHYROIDISM SECONDARY 15 0.0060
247 EYELID IRRITATION 15 0.0060
248 LIMB MASS 13 0.0059
249 GRIP STRENGTH DECREASED 52 0.0059
250 LOWER RESPIRATORY TRACT INFECTION 268 0.0059
251 IMPAIRED HEALING 193 0.0059
252 OSTEOLYSIS 12 0.0059
253 BREAST CANCER STAGE III 38 0.0059
254 LIVE BIRTH 49 0.0059
255 PSEUDOMEMBRANOUS COLITIS 13 0.0058
256 LUNG CONSOLIDATION 16 0.0057
257 DRUG TOLERANCE DECREASED 16 0.0057
258 HIP ARTHROPLASTY 87 0.0057
259 NIGHT SWEATS 183 0.0057
260 HEPATIC ENZYME INCREASED 383 0.0056
261 HYPOTHYROIDISM 178 0.0056
262 WOUND INFECTION 60 0.0055
263 CARDIAC DISCOMFORT 11 0.0055
264 TREATMENT FAILURE 452 0.0055
265 SWELLING OF EYELID 34 0.0054
266 RASH MORBILLIFORM 15 0.0054
267 PNEUMONIA VIRAL 17 0.0053
268 UPPER RESPIRATORY TRACT INFECTION 246 0.0053
269 UVEITIS 72 0.0053
270 BREATH SOUNDS ABNORMAL 26 0.0053
271 LIVER DISORDER 232 0.0052
272 KLEBSIELLA INFECTION 26 0.0051
273 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
274 TENOSYNOVITIS 14 0.0051
275 CLOSTRIDIUM TEST POSITIVE 11 0.0050
276 REBOUND ACID HYPERSECRETION 15 0.0050
277 TYPE 2 DIABETES MELLITUS 165 0.0049
278 INFUSION RELATED REACTION 321 0.0048
279 RESPIRATORY ACIDOSIS 19 0.0048
280 SCHIZOPHRENIA 58 0.0048
281 SYSTEMIC LUPUS ERYTHEMATOSUS 167 0.0047
282 ATYPICAL PNEUMONIA 14 0.0047
283 BRONCHOPULMONARY ASPERGILLOSIS 36 0.0046
284 PULMONARY MASS 69 0.0046
285 HEPATIC STEATOSIS 86 0.0046
286 LACRIMATION INCREASED 139 0.0046
287 PRODUCT PACKAGING DIFFICULT TO OPEN 12 0.0046
288 SLEEP APNOEA SYNDROME 87 0.0046
289 RASH VESICULAR 22 0.0045
290 GAIT INABILITY 152 0.0045
291 DEPRESSIVE SYMPTOM 16 0.0045
292 LUPUS-LIKE SYNDROME 41 0.0045
293 RED BLOOD CELL SEDIMENTATION RATE INCREASED 50 0.0045
294 ELECTROLYTE IMBALANCE 52 0.0045
295 NEPHROPATHY TOXIC 50 0.0044
296 ERYTHEMA OF EYELID 24 0.0044
297 POLYNEUROPATHY 53 0.0044
298 EYE IRRITATION 254 0.0044
299 STOMATITIS 265 0.0044
300 CARDIOPULMONARY FAILURE 17 0.0044
301 RETINAL ARTERY OCCLUSION 11 0.0043
302 OCULAR HYPERAEMIA 206 0.0043
303 OSTEOARTHRITIS 184 0.0043
304 EYE DISCHARGE 45 0.0043
305 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
306 BREAST CANCER STAGE II 36 0.0043
307 ROAD TRAFFIC ACCIDENT 181 0.0043
308 THERAPY NON-RESPONDER 193 0.0043
309 PSORIATIC ARTHROPATHY 172 0.0042
310 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 203 0.0042
311 HAEMODYNAMIC INSTABILITY 32 0.0042
312 MUSCULOSKELETAL PAIN 220 0.0042
313 PARANASAL SINUS HYPERSECRETION 16 0.0042
314 LUNG OPACITY 11 0.0042
315 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
316 WOUND SECRETION 16 0.0041
317 VITREOUS FLOATERS 40 0.0041
318 MULTIPLE ORGAN DYSFUNCTION SYNDROME 113 0.0040
319 ABSCESS LIMB 17 0.0040
320 TYPE I HYPERSENSITIVITY 14 0.0040
321 FOOT DEFORMITY 44 0.0040
322 IMMUNODEFICIENCY 59 0.0040
323 EMBOLISM VENOUS 12 0.0040
324 ELECTRIC SHOCK SENSATION 11 0.0039
325 PREGNANCY 78 0.0039
326 TENDON RUPTURE 48 0.0039
327 PLANTAR FASCIITIS 13 0.0039
328 COELIAC DISEASE 38 0.0039
329 THERAPEUTIC PRODUCT EFFECT DECREASED 172 0.0038
330 SKIN ODOUR ABNORMAL 15 0.0038
331 BLOOD BILIRUBIN INCREASED 103 0.0038
332 EYELID MARGIN CRUSTING 11 0.0038
333 DYSPNOEA AT REST 11 0.0038
334 GASTROINTESTINAL DISORDER 340 0.0038
335 WALKING AID USER 25 0.0038
336 PNEUMONIA 1226 0.0038
337 JOINT DISLOCATION 40 0.0038
338 SUBCUTANEOUS ABSCESS 18 0.0038
339 TINNITUS 172 0.0037
340 INFLAMMATION 193 0.0037
341 PSEUDOMONAS INFECTION 32 0.0037
342 THROMBOTIC THROMBOCYTOPENIC PURPURA 13 0.0037
343 EYE OPERATION 17 0.0037
344 CLOSTRIDIUM DIFFICILE COLITIS 39 0.0037
345 CYSTITIS 117 0.0037
346 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 261 0.0037
347 KNEE ARTHROPLASTY 77 0.0037
348 HYPERURICAEMIA 15 0.0036
349 HIV INFECTION 11 0.0036
350 EYE INJURY 11 0.0036
351 SKIN ABRASION 17 0.0036
352 FACIAL PAIN 32 0.0036
353 VENTRICULAR TACHYCARDIA 59 0.0036
354 HYPERBILIRUBINAEMIA 37 0.0036
355 VENTRICULAR ARRHYTHMIA 13 0.0036
356 SUPRAVENTRICULAR EXTRASYSTOLES 12 0.0035
357 AORTIC ANEURYSM 27 0.0035
358 EYE INFECTION 40 0.0035
359 PERIORBITAL SWELLING 20 0.0035
360 AMYLASE INCREASED 13 0.0035
361 BODY TEMPERATURE INCREASED 71 0.0035
362 BLOOD PRESSURE DIASTOLIC INCREASED 16 0.0035
363 VENTRICULAR EXTRASYSTOLES 36 0.0035
364 BLOOD CHOLESTEROL INCREASED 161 0.0035
365 JOINT SWELLING 414 0.0034
366 PULMONARY FUNCTION TEST DECREASED 15 0.0034
367 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 13 0.0034
368 EAR PAIN 66 0.0034
369 RETINAL DETACHMENT 31 0.0034
370 THROMBOCYTOPENIA 377 0.0034
371 TOXIC ENCEPHALOPATHY 17 0.0034
372 PSYCHOTIC DISORDER 99 0.0033
373 END STAGE RENAL DISEASE 61 0.0033
374 TRANSAMINASES INCREASED 73 0.0033
375 EYE SWELLING 122 0.0033
376 BLINDNESS UNILATERAL 46 0.0033
377 TOOTH ABSCESS 33 0.0032
378 NECROSIS 18 0.0032
379 RHEUMATOID ARTHRITIS 366 0.0032
380 AUTOIMMUNE HAEMOLYTIC ANAEMIA 11 0.0032
381 ORAL CANDIDIASIS 42 0.0032
382 PNEUMOCYSTIS JIROVECII PNEUMONIA 32 0.0032
383 ANAPHYLACTIC REACTION 176 0.0032
384 IMMUNOSUPPRESSION 28 0.0032
385 DEAFNESS 83 0.0032
386 VISUAL ACUITY REDUCED 105 0.0032
387 PNEUMONIA BACTERIAL 29 0.0032
388 FLUID RETENTION 160 0.0031
389 AORTIC DISSECTION 13 0.0031
390 ATELECTASIS 30 0.0031
391 SINUSITIS 318 0.0031
392 SUSPECTED OFF LABEL USE 14 0.0031
393 FIBRIN D DIMER INCREASED 11 0.0031
394 BLISTER 173 0.0031
395 CANDIDA INFECTION 52 0.0031
396 BLOOD PRESSURE SYSTOLIC INCREASED 60 0.0031
397 PRODUCT PRESCRIBING ISSUE 67 0.0031
398 JOINT EFFUSION 21 0.0030
399 HERPES ZOSTER 174 0.0030
400 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 158 0.0030
401 EOSINOPHILIA 53 0.0030
402 ABNORMAL SENSATION IN EYE 13 0.0030
403 PANCYTOPENIA 169 0.0030
404 MYOSITIS 27 0.0030
405 ARTHROPATHY 167 0.0030
406 BLEPHARITIS 12 0.0030
407 BRONCHITIS 219 0.0030
408 NICOTINE DEPENDENCE 23 0.0030
409 HYDROCEPHALUS 16 0.0029
410 CHRONIC SINUSITIS 11 0.0029
411 HEPATIC CIRRHOSIS 55 0.0029
412 PULMONARY EMBOLISM 278 0.0029
413 ASTHENOPIA 16 0.0029
414 SPINAL STENOSIS 12 0.0029
415 SEASONAL ALLERGY 41 0.0029
416 TUBULOINTERSTITIAL NEPHRITIS 54 0.0029
417 CLAVICLE FRACTURE 11 0.0029
418 TACHYPNOEA 39 0.0029
419 URINE ABNORMALITY 13 0.0029
420 HIDRADENITIS 26 0.0028
421 CLOSTRIDIUM DIFFICILE INFECTION 62 0.0028
422 MOBILITY DECREASED 202 0.0028
423 ACUTE RESPIRATORY FAILURE 54 0.0028
424 DISCOMFORT 171 0.0028
425 ACUTE HEPATIC FAILURE 38 0.0028
426 HYPERSENSITIVITY 514 0.0028
427 EOSINOPHIL COUNT INCREASED 23 0.0028
428 SKIN LACERATION 30 0.0028
429 HYPOMAGNESAEMIA 38 0.0027
430 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 24 0.0027
431 BENIGN PROSTATIC HYPERPLASIA 14 0.0027
432 CARDIAC FAILURE ACUTE 18 0.0027
433 RESPIRATORY FAILURE 197 0.0027
434 BLEPHAROSPASM 17 0.0027
435 CATARACT OPERATION 16 0.0027
436 MULTIPLE USE OF SINGLE-USE PRODUCT 15 0.0027
437 INTENTIONAL PRODUCT USE ISSUE 234 0.0027
438 GENERAL SYMPTOM 20 0.0027
439 EAR INFECTION 71 0.0027
440 C-REACTIVE PROTEIN INCREASED 97 0.0027
441 SENSITIVITY TO WEATHER CHANGE 14 0.0027
442 SWELLING 248 0.0026
443 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 145 0.0026
444 BLOOD PRESSURE SYSTOLIC DECREASED 12 0.0026
445 CONDITION AGGRAVATED 802 0.0026
446 PRODUCT ADMINISTRATION ERROR 53 0.0026
447 PRODUCT DELIVERY MECHANISM ISSUE 14 0.0026
448 PNEUMOTHORAX 41 0.0026
449 BLOOD PRESSURE DIASTOLIC DECREASED 19 0.0026
450 BLOOD MAGNESIUM DECREASED 22 0.0025
451 RENAL TUBULAR NECROSIS 25 0.0025
452 VOMITING 1198 0.0025
453 OSTEOMYELITIS 46 0.0025
454 DEAFNESS UNILATERAL 14 0.0025
455 CONJUNCTIVITIS 47 0.0025
456 CATARACT 150 0.0025
457 ENTERITIS 16 0.0025
458 MACULAR OEDEMA 14 0.0025
459 HEPATITIS CHOLESTATIC 15 0.0025
460 CHEST PAIN 460 0.0025
461 THROMBOSIS 199 0.0025
462 MUSCULOSKELETAL STIFFNESS 216 0.0025
463 DRUG INTERACTION 388 0.0024
464 BLOOD COUNT ABNORMAL 37 0.0024
465 INJURY 171 0.0024
466 DELIRIUM 84 0.0024
467 LYMPHOPENIA 34 0.0024
468 SLEEP DISORDER 169 0.0024
469 RETINAL HAEMORRHAGE 17 0.0024
470 BACTERAEMIA 28 0.0024
471 RHINITIS 19 0.0024
472 PNEUMONITIS 64 0.0023
473 CHOLELITHIASIS 77 0.0023
474 FACIAL PARALYSIS 20 0.0023
475 SKIN REACTION 33 0.0023
476 PHARYNGITIS 29 0.0023
477 ILL-DEFINED DISORDER 142 0.0023
478 STREPTOCOCCAL INFECTION 13 0.0023
479 DYSPNOEA 1318 0.0023
480 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 18 0.0023
481 ACUTE PULMONARY OEDEMA 13 0.0023
482 LOCALISED INFECTION 56 0.0023
483 HYPOALBUMINAEMIA 18 0.0023
484 HYPERTENSION 489 0.0023
485 FOETAL GROWTH RESTRICTION 14 0.0023
486 PRODUCT USE IN UNAPPROVED INDICATION 569 0.0023
487 RASH MACULO-PAPULAR 51 0.0023
488 CHRONIC KIDNEY DISEASE 174 0.0023
489 RESPIRATORY DISORDER 68 0.0023
490 HEPATITIS 58 0.0023
491 LEUKOPENIA 113 0.0023
492 DRY MOUTH 183 0.0023
493 ENTEROCOLITIS 13 0.0022
494 PERICARDIAL EFFUSION 52 0.0022
495 SKIN MASS 15 0.0022
496 FREQUENT BOWEL MOVEMENTS 60 0.0022
497 DECUBITUS ULCER 18 0.0022
498 ACUTE RESPIRATORY DISTRESS SYNDROME 39 0.0022
499 BACTERIAL INFECTION 41 0.0022
500 ODYNOPHAGIA 13 0.0022
501 VISION BLURRED 299 0.0022
502 INFECTION 315 0.0022
503 ENCEPHALITIS 15 0.0022
504 DRUG LEVEL DECREASED 22 0.0022
505 GENERAL PHYSICAL HEALTH DETERIORATION 249 0.0021
506 TRICUSPID VALVE INCOMPETENCE 17 0.0021
507 CACHEXIA 11 0.0021
508 ATRIAL FLUTTER 17 0.0021
509 COVID-19 PNEUMONIA 25 0.0021
510 THERAPY PARTIAL RESPONDER 33 0.0021
511 CARDIOMEGALY 26 0.0021
512 BLOOD IRON DECREASED 25 0.0021
513 APLASTIC ANAEMIA 11 0.0021
514 COUGH 587 0.0021
515 MIGRAINE 199 0.0021
516 MYELOSUPPRESSION 75 0.0021
517 NERVE INJURY 23 0.0021
518 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
519 PYREXIA 715 0.0021
520 LUNG INFECTION 32 0.0021
521 NEUROTOXICITY 36 0.0021
522 URTICARIA 343 0.0020
523 DECREASED IMMUNE RESPONSIVENESS 20 0.0020
524 HEPATOMEGALY 20 0.0020
525 PSYCHIATRIC SYMPTOM 15 0.0020
526 DRUG ERUPTION 36 0.0020
527 HYPOKALAEMIA 93 0.0020
528 HAEMOLYTIC ANAEMIA 18 0.0020
529 WEIGHT FLUCTUATION 21 0.0020
530 WHITE BLOOD CELL COUNT INCREASED 77 0.0020
531 DRUG LEVEL BELOW THERAPEUTIC 11 0.0020
532 ACUTE KIDNEY INJURY 305 0.0020
533 CONTUSION 191 0.0020
534 HALLUCINATION 149 0.0020
535 HYPOAESTHESIA 295 0.0020
536 OSTEOPOROSIS 81 0.0020
537 CYTOPENIA 24 0.0020
538 BLOOD CALCIUM DECREASED 22 0.0020
539 IRON DEFICIENCY ANAEMIA 18 0.0019
540 MYDRIASIS 25 0.0019
541 ASPARTATE AMINOTRANSFERASE INCREASED 103 0.0019
542 QUALITY OF LIFE DECREASED 26 0.0019
543 SPINAL OSTEOARTHRITIS 17 0.0019
544 DERMATITIS BULLOUS 14 0.0019
545 MYOCARDIAL ISCHAEMIA 22 0.0019
546 LUNG INFILTRATION 17 0.0019
547 GLAUCOMA 37 0.0019
548 RESPIRATORY DISTRESS 53 0.0019
549 OEDEMA PERIPHERAL 234 0.0019
550 ANXIETY 546 0.0019
551 PHOTOPSIA 12 0.0019
552 PARAESTHESIA 298 0.0019
553 ALANINE AMINOTRANSFERASE INCREASED 116 0.0019
554 OXYGEN SATURATION DECREASED 106 0.0019
555 EMPHYSEMA 19 0.0019
556 GENERALISED TONIC-CLONIC SEIZURE 31 0.0019
557 DISABILITY 37 0.0019
558 FEBRILE NEUTROPENIA 124 0.0019
559 SCAR 32 0.0019
560 GASTROOESOPHAGEAL REFLUX DISEASE 150 0.0019
561 SEPTIC SHOCK 81 0.0019
562 STENT PLACEMENT 15 0.0019
563 PRESCRIBED UNDERDOSE 37 0.0019
564 MYOPATHY 16 0.0019
565 STAPHYLOCOCCAL INFECTION 61 0.0018
566 STEVENS-JOHNSON SYNDROME 41 0.0018
567 PROTHROMBIN TIME PROLONGED 11 0.0018
568 MATERNAL EXPOSURE DURING PREGNANCY 163 0.0018
569 BODY TEMPERATURE DECREASED 18 0.0018
570 BRONCHOSPASM 26 0.0018
571 ABDOMINAL DISCOMFORT 305 0.0018
572 RASH 789 0.0018
573 EYELID OEDEMA 21 0.0018
574 PANIC REACTION 13 0.0018
575 COAGULOPATHY 30 0.0018
576 MALNUTRITION 20 0.0018
577 CONCOMITANT DISEASE AGGRAVATED 11 0.0018
578 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
579 BLOOD ALBUMIN DECREASED 14 0.0018
580 ABSCESS 28 0.0018
581 VISUAL IMPAIRMENT 217 0.0017
582 ANAPHYLACTIC SHOCK 45 0.0017
583 NEURALGIA 42 0.0017
584 DEVICE USE ISSUE 30 0.0017
585 DIARRHOEA HAEMORRHAGIC 16 0.0017
586 CARDIAC FAILURE 137 0.0017
587 ABDOMINAL PAIN UPPER 351 0.0017
588 BLOOD SODIUM DECREASED 32 0.0017
589 OFF LABEL USE 1485 0.0017
590 NASOPHARYNGITIS 312 0.0017
591 HEPATIC FAILURE 51 0.0017
592 HAEMOLYSIS 13 0.0017
593 LUNG NEOPLASM MALIGNANT 69 0.0017
594 CONFUSIONAL STATE 271 0.0017
595 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
596 ANAL INCONTINENCE 15 0.0017
597 LYMPHADENOPATHY 59 0.0017
598 EYE PRURITUS 56 0.0017
599 MALAISE 729 0.0017
600 OROPHARYNGEAL DISCOMFORT 15 0.0017
601 BACK DISORDER 27 0.0017
602 MENINGITIS 11 0.0016
603 ANAEMIA 314 0.0016
604 MUSCULOSKELETAL DISCOMFORT 28 0.0016
605 HYPOPHOSPHATAEMIA 12 0.0016
606 VENTRICULAR FIBRILLATION 18 0.0016
607 HYPONATRAEMIA 91 0.0016
608 PRODUCT USE ISSUE 303 0.0016
609 HEPATIC FUNCTION ABNORMAL 60 0.0016
610 SKIN INFECTION 18 0.0016
611 SKIN LESION 44 0.0016
612 AGITATION 117 0.0016
613 PSORIASIS 208 0.0016
614 PURPURA 14 0.0016
615 HYPERHIDROSIS 202 0.0016
616 DYSPNOEA EXERTIONAL 59 0.0016
617 DRY EYE 78 0.0016
618 GASTROINTESTINAL INFECTION 14 0.0016
619 DIVERTICULUM 11 0.0015
620 RENAL IMPAIRMENT 130 0.0015
621 EXPOSURE DURING PREGNANCY 96 0.0015
622 PERIPHERAL SWELLING 237 0.0015
623 MULTIPLE ALLERGIES 12 0.0015
624 PLEURAL EFFUSION 93 0.0015
625 CIRCULATORY COLLAPSE 26 0.0015
626 DECREASED APPETITE 353 0.0015
627 RASH ERYTHEMATOUS 72 0.0015
628 HYPOTONIA 15 0.0015
629 MITRAL VALVE INCOMPETENCE 17 0.0015
630 PYELONEPHRITIS 13 0.0015
631 TRANSPLANT REJECTION 12 0.0015
632 DISSEMINATED INTRAVASCULAR COAGULATION 21 0.0015
633 TOXIC SKIN ERUPTION 15 0.0015
634 HEPATOCELLULAR INJURY 21 0.0015
635 SINUS TACHYCARDIA 21 0.0015
636 SHOCK 34 0.0015
637 COLITIS ULCERATIVE 66 0.0015
638 HEMIPARESIS 25 0.0015
639 DISEASE PROGRESSION 174 0.0015
640 PRODUCT USE COMPLAINT 23 0.0015
641 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 25 0.0015
642 ECONOMIC PROBLEM 22 0.0015
643 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
644 PAIN 891 0.0014
645 DRUG LEVEL INCREASED 24 0.0014
646 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
647 JAUNDICE 39 0.0014
648 CYTOMEGALOVIRUS INFECTION 24 0.0014
649 NEUTROPENIA 195 0.0014
650 PHARYNGEAL SWELLING 14 0.0014
651 FISTULA 16 0.0014
652 SUDDEN DEATH 15 0.0014
653 BLOOD POTASSIUM DECREASED 42 0.0014
654 PHOTOSENSITIVITY REACTION 23 0.0014
655 HAEMOGLOBIN DECREASED 143 0.0014
656 NEPHROPATHY 13 0.0014
657 HIATUS HERNIA 18 0.0014
658 ABDOMINAL PAIN 323 0.0014
659 ARTHRITIS 109 0.0014
660 MUSCLE SPASTICITY 17 0.0014
661 LEUKOCYTOSIS 25 0.0014
662 PANCREATITIS ACUTE 31 0.0014
663 MUCOSAL INFLAMMATION 36 0.0014
664 SKIN EXFOLIATION 116 0.0014
665 ANHEDONIA 36 0.0014
666 SPLENOMEGALY 16 0.0014
667 TREATMENT NONCOMPLIANCE 74 0.0014
668 VIRAL INFECTION 45 0.0014
669 BRAIN OEDEMA 17 0.0013
670 RENAL FAILURE 178 0.0013
671 BLOOD PRESSURE FLUCTUATION 32 0.0013
672 INTERNATIONAL NORMALISED RATIO INCREASED 38 0.0013
673 HYPOPHAGIA 34 0.0013
674 SEPSIS 148 0.0013
675 PANCREATITIS 70 0.0013
676 ARRHYTHMIA 62 0.0013
677 CARDIAC FAILURE CONGESTIVE 105 0.0013
678 LYMPHOCYTE COUNT DECREASED 23 0.0013
679 DEVICE RELATED INFECTION 20 0.0013
680 INCORRECT PRODUCT ADMINISTRATION DURATION 28 0.0013
681 ANGIOEDEMA 57 0.0013
682 MEDICATION ERROR 71 0.0013
683 GASTROINTESTINAL PAIN 14 0.0013
684 BLOOD CREATININE INCREASED 83 0.0013
685 TOOTHACHE 23 0.0013
686 ARTHRALGIA 526 0.0013
687 MUSCLE SPASMS 232 0.0013
688 RIB FRACTURE 26 0.0013
689 ATAXIA 15 0.0013
690 SINUS DISORDER 25 0.0013
691 MENTAL STATUS CHANGES 35 0.0013
692 TEMPERATURE INTOLERANCE 13 0.0013
693 NASAL CONGESTION 74 0.0013
694 RESPIRATORY TRACT CONGESTION 20 0.0013
695 RENAL INJURY 37 0.0012
696 DEPRESSION 283 0.0012
697 HYPERTHYROIDISM 18 0.0012
698 RESPIRATORY RATE INCREASED 11 0.0012
699 GASTROENTERITIS 18 0.0012
700 DIPLOPIA 32 0.0012
701 MUSCULAR WEAKNESS 140 0.0012
702 VITAMIN D DEFICIENCY 12 0.0012
703 ASCITES 36 0.0012
704 METABOLIC ACIDOSIS 39 0.0012
705 DISEASE RECURRENCE 58 0.0012
706 APHONIA 17 0.0012
707 GASTRITIS 32 0.0012
708 TACHYCARDIA 108 0.0012
709 PLATELET COUNT DECREASED 129 0.0012
710 PAIN IN EXTREMITY 356 0.0012
711 RHINORRHOEA 78 0.0012
712 SECRETION DISCHARGE 15 0.0012
713 BLOOD UREA INCREASED 20 0.0012
714 OESOPHAGITIS 13 0.0012
715 THERAPY INTERRUPTED 85 0.0012
716 PERITONITIS BACTERIAL 12 0.0012
717 INTENTIONAL PRODUCT MISUSE 104 0.0012
718 SINUS CONGESTION 16 0.0012
719 ERYTHEMA MULTIFORME 11 0.0012
720 WEIGHT INCREASED 264 0.0012
721 BLINDNESS 48 0.0012
722 HEPATIC CYTOLYSIS 15 0.0012
723 IMPAIRED GASTRIC EMPTYING 16 0.0012
724 EAR DISCOMFORT 12 0.0012
725 HEPATITIS C 14 0.0012
726 DIARRHOEA 748 0.0012
727 ALOPECIA 227 0.0012
728 LABORATORY TEST ABNORMAL 34 0.0012
729 CYTOKINE RELEASE SYNDROME 23 0.0011
730 ASTHENIA 431 0.0011
731 MASS 16 0.0011
732 JOINT STIFFNESS 30 0.0011
733 HYPOACUSIS 49 0.0011
734 AMNESIA 74 0.0011
735 UNDERDOSE 83 0.0011
736 HEART RATE INCREASED 111 0.0011
737 LIVER FUNCTION TEST INCREASED 24 0.0011
738 HYPOCALCAEMIA 21 0.0011
739 NAUSEA 876 0.0011
740 OROPHARYNGEAL PAIN 102 0.0011
741 DYSPEPSIA 108 0.0011
742 DRUG INEFFECTIVE 1445 0.0011
743 SEROTONIN SYNDROME 21 0.0011
744 CELLULITIS 55 0.0011
745 HYPOTHERMIA 11 0.0011
746 HYPERKALAEMIA 38 0.0011
747 SKIN ULCER 28 0.0011
748 CARDIOMYOPATHY 16 0.0011
749 BONE MARROW FAILURE 22 0.0011
750 PRURITUS 413 0.0011
751 NEUTROPHIL COUNT INCREASED 11 0.0011
752 PULMONARY OEDEMA 48 0.0011
753 MIDDLE INSOMNIA 20 0.0011
754 RECTAL HAEMORRHAGE 46 0.0011
755 SNEEZING 24 0.0011
756 CARDIAC ARREST 88 0.0011
757 BEDRIDDEN 14 0.0011
758 IMMUNE SYSTEM DISORDER 14 0.0011
759 OSTEOPENIA 16 0.0011
760 FUNGAL INFECTION 35 0.0010
761 DIZZINESS 522 0.0010
762 CHEST DISCOMFORT 107 0.0010
763 BONE DISORDER 19 0.0010
764 WEIGHT DECREASED 289 0.0010
765 MENTAL DISORDER 45 0.0010
766 DERMATITIS ALLERGIC 13 0.0010
767 LIMB INJURY 28 0.0010
768 FLUID OVERLOAD 15 0.0010
769 FEELING HOT 63 0.0010
770 MUSCLE ATROPHY 13 0.0010
771 SPINAL PAIN 12 0.0010
772 FATIGUE 792 0.0010
773 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
774 HAEMATOCRIT DECREASED 20 0.0010
775 PULMONARY HYPERTENSION 21 0.0010
776 CHOLECYSTITIS 12 0.0010
777 MYALGIA 171 0.0010
778 MACULAR DEGENERATION 12 0.0010
779 PNEUMONIA ASPIRATION 25 0.0010
780 HYPOTENSION 200 0.0010
781 HALLUCINATION, VISUAL 21 0.0010
782 LIP SWELLING 33 0.0010
783 LACTIC ACIDOSIS 32 0.0010
784 PULMONARY CONGESTION 13 0.0010
785 HEADACHE 618 0.0010
786 DISORIENTATION 39 0.0010
787 JOINT INJURY 21 0.0010
788 IMPAIRED WORK ABILITY 21 0.0010
789 PALPITATIONS 115 0.0010
790 ANGINA PECTORIS 28 0.0010
791 PHARYNGEAL OEDEMA 15 0.0010
792 DYSPHONIA 57 0.0010
793 EYE DISORDER 32 0.0010
794 PARAESTHESIA ORAL 14 0.0010
795 FEELING COLD 27 0.0010
796 MUSCULOSKELETAL CHEST PAIN 15 0.0010
797 DERMATITIS CONTACT 11 0.0010
798 HYPERGLYCAEMIA 35 0.0010
799 ATRIAL FIBRILLATION 93 0.0010
800 FRACTURE 18 0.0009
801 GAIT DISTURBANCE 182 0.0009
802 RENAL FAILURE ACUTE 40 0.0009
803 CHOLESTASIS 18 0.0009
804 ADVERSE DRUG REACTION 84 0.0009
805 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
806 BLOOD PRESSURE DECREASED 61 0.0009
807 PAIN IN JAW 26 0.0009
808 EPILEPSY 28 0.0009
809 TOOTH INFECTION 12 0.0009
810 RED BLOOD CELL COUNT DECREASED 26 0.0009
811 SARS-COV-2 TEST POSITIVE 12 0.0009
812 MYELODYSPLASTIC SYNDROME 13 0.0009
813 CARDIAC DISORDER 84 0.0009
814 BASAL CELL CARCINOMA 14 0.0009
815 HYPERCALCAEMIA 11 0.0009
816 SWELLING FACE 58 0.0009
817 TOXICITY TO VARIOUS AGENTS 148 0.0009
818 ACCIDENTAL OVERDOSE 32 0.0009
819 GASTROINTESTINAL HAEMORRHAGE 73 0.0009
820 HAEMORRHOIDS 17 0.0009
821 PLASMA CELL MYELOMA 34 0.0009
822 MULTI-ORGAN FAILURE 15 0.0009
823 RASH PRURITIC 47 0.0009
824 NERVOUS SYSTEM DISORDER 27 0.0009
825 DEEP VEIN THROMBOSIS 56 0.0009
826 ORTHOSTATIC HYPOTENSION 15 0.0009
827 CORONARY ARTERY DISEASE 26 0.0009
828 ROTATOR CUFF SYNDROME 11 0.0009
829 BLOOD PRESSURE ABNORMAL 17 0.0009
830 HEART RATE DECREASED 30 0.0009
831 PRODUCT DOSE OMISSION ISSUE 251 0.0009
832 OSTEONECROSIS 28 0.0009
833 DYSARTHRIA 32 0.0008
834 OSTEONECROSIS OF JAW 21 0.0008
835 CHILLS 99 0.0008
836 PLATELET COUNT INCREASED 11 0.0008
837 THYROID DISORDER 13 0.0008
838 SPEECH DISORDER 44 0.0008
839 DELUSION 13 0.0008
840 ACUTE MYELOID LEUKAEMIA 13 0.0008
841 INTERSTITIAL LUNG DISEASE 40 0.0008
842 SYNCOPE 82 0.0008
843 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24 0.0008
844 DISTURBANCE IN ATTENTION 44 0.0008
845 WHITE BLOOD CELL COUNT DECREASED 87 0.0008
846 HYPERSOMNIA 23 0.0008
847 AGEUSIA 20 0.0008
848 RETCHING 17 0.0008
849 HEART RATE IRREGULAR 18 0.0008
850 ADVERSE EVENT 73 0.0008
851 RHABDOMYOLYSIS 33 0.0008
852 POOR QUALITY SLEEP 17 0.0008
853 EPISTAXIS 59 0.0008
854 VERTIGO 48 0.0008
855 GALLBLADDER DISORDER 14 0.0008
856 PRESYNCOPE 19 0.0008
857 GOUT 14 0.0008
858 EJECTION FRACTION DECREASED 12 0.0008
859 FACE OEDEMA 13 0.0008
860 MYOCARDIAL INFARCTION 134 0.0008
861 HAEMATURIA 26 0.0008
862 CHROMATURIA 17 0.0008
863 BLOOD PRESSURE INCREASED 115 0.0008
864 BACK PAIN 173 0.0007
865 CONSTIPATION 162 0.0007
866 MEMORY IMPAIRMENT 102 0.0007
867 TASTE DISORDER 15 0.0007
868 DEPRESSED MOOD 39 0.0007
869 HOSPITALISATION 113 0.0007
870 HAEMATOMA 19 0.0007
871 ENCEPHALOPATHY 18 0.0007
872 BURNING SENSATION 51 0.0007
873 INSOMNIA 192 0.0007
874 ABDOMINAL DISTENSION 75 0.0007
875 ABDOMINAL PAIN LOWER 18 0.0007
876 LIMB DISCOMFORT 22 0.0007
877 CARDIOVASCULAR DISORDER 18 0.0007
878 FEAR 19 0.0007
879 SEIZURE 81 0.0007
880 PREMATURE BABY 21 0.0007
881 ERYTHEMA 143 0.0007
882 MUSCLE TWITCHING 16 0.0007
883 COVID-19 121 0.0007
884 FEELING ABNORMAL 165 0.0007
885 FLATULENCE 39 0.0007
886 LIVER FUNCTION TEST ABNORMAL 20 0.0007
887 PANIC ATTACK 25 0.0007
888 URINARY TRACT INFECTION 117 0.0007
889 PROTEINURIA 13 0.0007
890 HERNIA 13 0.0007
891 CARDIO-RESPIRATORY ARREST 28 0.0007
892 SUICIDAL IDEATION 61 0.0007
893 GASTROENTERITIS VIRAL 12 0.0007
894 DYSPHAGIA 63 0.0007
895 MENTAL IMPAIRMENT 16 0.0007
896 TREMOR 109 0.0007
897 INFLUENZA 73 0.0007
898 DIVERTICULITIS 18 0.0006
899 GASTRIC DISORDER 22 0.0006
900 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
901 DYSKINESIA 26 0.0006
902 HYPOGLYCAEMIA 31 0.0006
903 NIGHTMARE 22 0.0006
904 PRODUCT PRESCRIBING ERROR 15 0.0006
905 APHASIA 19 0.0006
906 FOETAL EXPOSURE DURING PREGNANCY 51 0.0006
907 NECK PAIN 35 0.0006
908 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
909 MOVEMENT DISORDER 20 0.0006
910 UNRESPONSIVE TO STIMULI 16 0.0006
911 RESTLESSNESS 22 0.0006
912 FALL 198 0.0006
913 NEUTROPHIL COUNT DECREASED 24 0.0006
914 PALLOR 16 0.0006
915 BRADYCARDIA 31 0.0006
916 DIABETIC KETOACIDOSIS 14 0.0006
917 FOOT FRACTURE 11 0.0006
918 SOMNOLENCE 116 0.0006
919 SKIN DISCOLOURATION 26 0.0006
920 DYSGEUSIA 42 0.0006
921 ORAL HERPES 11 0.0006
922 KIDNEY INFECTION 11 0.0006
923 LETHARGY 32 0.0006
924 DEHYDRATION 74 0.0006
925 MELAENA 12 0.0005
926 SWOLLEN TONGUE 17 0.0005
927 ILLNESS 56 0.0005
928 HAEMATOCHEZIA 30 0.0005
929 DYSURIA 20 0.0005
930 LOSS OF CONSCIOUSNESS 69 0.0005
931 THROAT IRRITATION 24 0.0005
932 CEREBRAL INFARCTION 13 0.0005
933 INTESTINAL OBSTRUCTION 20 0.0005
934 THERAPY CESSATION 27 0.0005
935 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 104 0.0005
936 DIABETES MELLITUS 39 0.0005
937 ACUTE MYOCARDIAL INFARCTION 15 0.0005
938 PRURITUS GENERALISED 11 0.0005
939 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 87 0.0005
940 EMOTIONAL DISTRESS 58 0.0005
941 COLITIS 18 0.0005
942 BALANCE DISORDER 41 0.0005
943 MALIGNANT NEOPLASM PROGRESSION 48 0.0005
944 COMA 22 0.0005
945 NEPHROLITHIASIS 21 0.0005
946 RENAL DISORDER 21 0.0005
947 THROAT TIGHTNESS 12 0.0004
948 HEAD INJURY 14 0.0004
949 DEATH 375 0.0004
950 DEMENTIA 12 0.0004
951 ABNORMAL BEHAVIOUR 17 0.0004
952 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
953 CEREBRAL HAEMORRHAGE 15 0.0004
954 CRYING 15 0.0004
955 BONE PAIN 24 0.0004
956 NEOPLASM PROGRESSION 14 0.0004
957 THERAPEUTIC RESPONSE DECREASED 24 0.0004
958 DYSSTASIA 11 0.0004
959 ABORTION SPONTANEOUS 15 0.0004
960 OVERDOSE 80 0.0004
961 HAEMORRHAGE 38 0.0004
962 URINARY RETENTION 12 0.0004
963 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
964 RASH MACULAR 12 0.0003
965 HOT FLUSH 25 0.0003
966 BLOOD GLUCOSE INCREASED 62 0.0003
967 INFLUENZA LIKE ILLNESS 27 0.0003
968 FLUSHING 33 0.0003
969 NEOPLASM MALIGNANT 21 0.0003
970 DRUG EFFECT INCOMPLETE 11 0.0003
971 COGNITIVE DISORDER 14 0.0003
972 DRY SKIN 39 0.0003
973 CEREBROVASCULAR ACCIDENT 47 0.0003
974 POLLAKIURIA 11 0.0003
975 CONVULSION 15 0.0003
976 AGGRESSION 12 0.0002
977 UNEVALUABLE EVENT 18 0.0002
978 NERVOUSNESS 12 0.0002
979 ECZEMA 12 0.0002
980 NO ADVERSE EVENT 41 0.0002
981 IRRITABILITY 13 0.0002
982 PRODUCT STORAGE ERROR 17 0.0002
983 INCORRECT DOSE ADMINISTERED 44 0.0002
984 INJECTION SITE BRUISING 15 0.0002
985 INJECTION SITE REACTION 12 0.0002
986 INJECTION SITE HAEMORRHAGE 13 0.0002
987 ACNE 12 0.0002
988 PRODUCT QUALITY ISSUE 21 0.0002
989 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
990 INJECTION SITE PAIN 28 0.0001